Oleg Movchan - 05 Mar 2024 Form 4 Insider Report for Enfusion, Inc.

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact for Oleg Movchan
Issuer symbol
N/A
Transactions as of
05 Mar 2024
Net transactions value
$0
Form type
4
Filing time
07 Mar 2024, 17:15:56 UTC
Previous filing
05 Mar 2024
Next filing
10 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +100,000 +36% $0.000000 379,772 05 Mar 2024 Direct F2
transaction ENFN Class A Common Stock Award $0 +149,701 +39% $0.000000 529,473 05 Mar 2024 Direct F3
holding ENFN Class A Common Stock 1,151,818 05 Mar 2024 By CSL Tech Holdings, LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Oleg Movchan is a co-manager of CSL Tech Holdings, LLC. Mr. Movchan may be deemed to have shared voting and dispositive power over the shares of Class A common stock held by CSL Tech Holdings, LLC. Mr. Movchan disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F2 Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full if certain performance milestones are achieved on or prior to March 5, 2027.
F3 Consists of RSUs awarded pursuant to the Plan. The RSUs will vest in full as follows: 37,426, 37,425, 37,425, 37,425 on each of March 5, 2025, 2026, 2027 and 2028, respectively.